Manke Isaac bought OKUR
December 31, 2025 · Form 4 insider transaction
Manke Isaac bought 5,258 shares of OnKure Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,258
Price
$0.00
Total value
N/A
InsiderManke Isaac
RoleDirector
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 2, 2026
Shares owned after20,583
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.